9th November 2009 - New data from Puredel Limited, presented at the 9th Annual Diabetes Technology Meeting in San Francisco, California, suggest that higher blood levels of insulin were achieved by Ossulin than had been prevously demonstrated by other products. In a series of experiements in a range of doses and models, Ossulin consistently delivered around 20% of the insulin dose into the bloodstream.The authors concluded that:
'Ossulin provides an efficient way to deliver insulin to the body by oral administration, resulting in blood levels higher than those previously observed with other oral insulin products.'... CM&D Pharma' Press Release -
